No drugs for Alzheimer's disease, which is a mental condition that erodes memory and other capabilities have been approved by the FDA despite over 5 million Americans affected. Now a paper by an MIT professor suggests that a revamped way of financing Alzheimer's research could spur the development of useful new drugs for the illness. "We are spending tremendous amounts of resources dealing with this disease, but we don't have any effective therapies for it," says ...
Read More
You have just read an article categorized health
titled New Approach to Funding Alzheimer's Research Could Pay Off.
Written by:
editor -
Thursday, June 19, 2014
There are currently no comments for "New Approach to Funding Alzheimer's Research Could Pay Off"
Post a Comment